Primary Carcinoma of the Fallopian Tube

Raju, K. S.; Barker, Graham; Wiltshaw, E.

doi:10.1111/j.1471-0528.1981.tb01766.x

Cited by 48 publications

(22 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Primary malignant tumors of the fallopian tube account for 0.3-1.9% of gynecological malignancies (6). Benign tumors of the fallopian tube are even less common, the majority being adenomatoid tumors (7).…”

Section: Discussionmentioning

confidence: 99%

Synchronous occurrence of mature cystic teratoma of the fallopian tube and ovary: A case report

Baek

2016

Oncology Letters

View full text Add to dashboard Cite

Abstract. Primary carcinoma of the fallopian tube represents <1% of all gynecological tumors, and benign tumors of the fallopian tube are encountered even less frequently. Mature teratomas of the fallopian tube and ovary are extremely rare, and to date, only a few cases have been reported. A 31-year-old woman presented with a left adnexal mass that was identified by pelvic ultrasonography during a regular checkup. The patient underwent laparoscopic left salpingectomy and left ovarian cystectomy. Histopathological examination of the removed tissue revealed features compatible with mature cystic teratomas of both the left fallopian tube and ovary. At 26 months post-surgery, the patient underwent a cesarean section at 39+2 weeks of gestation. A right ovarian cystic mass was incidentally identified during the procedure. Right ovarian cystectomy was performed, and histopathological analysis revealed the mass to be a teratoma. The patient continued to receive annual follow-up after surgical intervention and demonstrated no evidence of disease at a routine 2-year follow-up examination. The discussion of the present case is followed by a brief review of the literature.

show abstract

Section: Discussionmentioning

confidence: 99%

Synchronous occurrence of mature cystic teratoma of the fallopian tube and ovary: A case report

Baek

2016

Oncology Letters

View full text Add to dashboard Cite

show abstract

“…There are very few data that are extractable from the literature with regard to PFTC. Several authors using cisplatin-based chemotherapy in patients with advanced PFTC reported overall responses rates of 53%-92% [4,49,50,68,70,92,94,96,99]. Peters et al [50] reported a 75% complete response rate in a study of 46 patients with advanced or recurrent PFTC.…”

Section: Combination Chemotherapy For Advanced Diseasementioning

confidence: 99%

“…Primary fallopian tube carcinoma (PFTC) is an uncommon tumor accounting for approximately 0.14%-1.8% of female genital malignancies [1][2][3][4][5][6][7]. It is estimated, based on the data obtained from nine population-based cancer registries in the U.S., that the average annual incidence of PFTC is 3.6 per million women per year [8].…”

Section: Introductionmentioning

confidence: 99%

Fallopian Tube Carcinoma: A Review

2006

View full text Add to dashboard Cite

Purpose. Primary fallopian tube carcinoma (PFTC) is a rare tumor that histologically and clinically resembles epithelial ovarian cancer (EOC). The purpose of this study is to review the current available literature data on PFTC.Patients and Results. Early clinical manifestation and prompt investigation often lead to diagnosis at an early stage of disease. However, the diagnosis of PFTC is rarely considered preoperatively and is usually first appreciated by the pathologist. Surgical staging/management and the use of chemotherapy follow the concepts used in epithelial ovarian cancer (EOC). In contrast to EOC is the importance of early lymphatic spread in this disease. The earlier diagnosis of PFTC leads to an apparent better survival compared with EOC. However, as with EOC, stage and residual tumor are the most important prognostic variables.Conclusion. Until more extensive clinical research has been performed, ovarian carcinoma management principles should be used in clinical practice. The Oncologist 2006;11:902-912

show abstract

“…Deppe et al (1980) described two patients with advanced adenocarcinoma of the fallopian tube treated with a combination of adriamycin, cis-platinum, cyclophosphamide and progestin who achieved a complete pathological remission. Raju & Wiltshaw (1981) reported one complete pathological remission and one partial remission in 2 of 4 patients treated with cis-platinum. The two non-responders in their study were given cis-platinum at a low dose (20 mg/M2) in combination with chlorambucil.…”

Section: Discussionmentioning

confidence: 99%

“…Primary adenocarcinoma of the fallopian tube is a rare tumour of the female genital tract, with a reported incidence between 0.3% and 1.6% (Raju & Wiltshaw 1981). The prognosis following surgery remains poor (Schiller & Silverberg 1971), and due to the rarity of the tumour the efficacy of adjuvant radiotherapy and chemotherapy is not yet established.…”

Section: Introductionmentioning

confidence: 99%